::: Formosa Laboratories, Inc. :::

About Us Products Custom Synthesis Quality & Compliance An Investigational New Drug application (IND) has been submitted to the US FDA for MTP0E028, a novel HDAC inhibitor targeting solid tumor indications and co-developed by Taipei Medical ...

www.formosalab.com